NUZ 2.50% 19.5¢ neurizon therapeutics limited

Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-319

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 518 Posts.
    lightbulb Created with Sketch. 257
    How much longer do we hold out hope for this stock? Must say I am running out of patience at a rapid rate.

    I am beginning to think that Bucky is closer to the reality of this stock than many of the other “glass half full” posters on the HC forum. PAA has had plenty of time to achieve something, but thus far achieved f@#k all. It’s OK to try to maintain a positive vibe, as most PAA HC posters continue to do, but at some stage you need to ask the question, when is enough - enough?

    I do believe in MPL and it’s medical potential, but current PAA management seem to not have the ability and/or capability to get it to market on any level.

    The sp seemingly unable to stay above .10 cents shows the market has also lost patience and faith in current management.

    All the “glass half full” HCers out there reading this, will tell me to sell up and buggar off, if I am not happy with progress. But, the facts are the facts, PAA are spinning their wheels and delivering very little.

    My strategy is to give it a little more time, possibly the end of 2021, and if nothing improves, will sell at a substantial loss and move on. Let’s hope this action is not required.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.005(2.50%)
Mkt cap ! $94.89M
Open High Low Value Volume
20.0¢ 20.3¢ 19.5¢ $124.5K 628.4K

Buyers (Bids)

No. Vol. Price($)
2 2791 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 62424 2
View Market Depth
Last trade - 15.39pm 01/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.